Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.57 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25328235 | 0.87 | THRB (0.77) | THRBHDAC1HDAC6MEN1KMT2A | |
| SCHEMBL14415899 | 0.87 | THRB (0.77) | THRBHDAC1HDAC6MEN1KMT2A | |
| SCHEMBL30664046 | 0.86 | THRB (0.75) | THRBHDAC1HDAC6MEN1KMT2A | |
| Nicotinuric Acid SCHEMBL351962 | 0.86 | THRB (0.75) | THRBHDAC1HDAC6MEN1KMT2A | |
| SCHEMBL3864600 | 0.86 | THRB (0.75) | THRBHDAC1HDAC6MEN1KMT2A | |
| Nicotinuric Acid SCHEMBL30183567 | 0.86 | THRB (0.75) | THRBHDAC1HDAC6MEN1KMT2A | |
| SCHEMBL62572 | 0.86 | THRB (0.75) | THRBHDAC1HDAC6MEN1KMT2A | |
| SCHEMBL20663433 | 0.85 | THRB (0.73) | THRBHDAC1HDAC6MEN1KMT2A | |
| SCHEMBL1687071 | 0.84 | THRB (0.73) | THRBHDAC1HDAC6MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7321595 | 0.84 | THRB (0.73) | THRBHDAC1HDAC6MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 744 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094660-A | Composition in the form of an oil-in-water emulsion | — | 2026-05-26 | — | — | CN | claimed |
| EP-4687829-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-02-11 | — | — | EP | claimed |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | OREAL (FR) | 2025-12-18 | — | — | US | claimed |
| US-20250271424-A1 | TARGET INTERFERENCE SUPPRESSED ANTI-DRUG ANTIBODY ASSAY | HOFFMANN-LA ROCHE INC. | 2025-08-28 | — | — | US | claimed |
| WO-2025091220-A2 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| WO-2025091239-A1 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| EP-4528277-A2 | TARGET INTERFERENCE SUPPRESSED ANTI-DRUG ANTIBODY ASSAY | F. Hoffmann-La Roche AG (CH) | 2025-03-26 | — | — | EP | claimed |
| CN-119680635-A | Ionic liquid catalyst for producing renewable fuel from waste grease and preparation method and application thereof | 中国科学院青岛生物能源与过程研究所 | 2025-03-25 | — | — | CN | claimed |
| CN-119654151-A | Composition for caring skin | 莱雅公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119630382-A | Solubilization of thiopyridone compounds and compositions containing same | 莱雅公司 | 2025-03-14 | — | — | CN | claimed |
| EP-0896522-B1 | METHODS OF REGULATING SKIN APPEARANCE WITH VITAMIN B 3 COMPOUND | PROCTER & GAMBLE (US) | 2003-10-22 | — | — | EP | claimed |
| US-6383476-B1 | Anhydrous antiperspirant and deodorant compositions containing a solid, water-soluble, skin active agent | THE PROCTER & GAMBLE COMPANY | 2002-05-07 | — | — | US | claimed |
| WO-2001079212-A1 | SILICON DERIVATIVES OF FRAGRANT, FLAVOURING AND MEDICINAL SUBSTANCES | KIREEV VYACHESLAV VASILIEVICH (RU) | 2001-10-25 | — | — | WO | claimed |
| EP-0705868-B1 | Regenerated cellulose-based materials having a high bleach resistance, and process for preparing them | ELYSEES BALZAC FINANCIERE (FR) | 1999-12-08 | — | — | EP | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | claimed |
| EP-0705868-A1 | Regenerated cellulose-based materials having a high bleach resistance, and process for preparing them | FINANCIERE ELYSEES BALZAC (FR) | 1996-04-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | TBCB, CCNB3, CYP24A1 | THRB 494/4885HDAC1 3263/4885HDAC6 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.